来宝网 2014/12/22点击2052次
中国药物筛选的平台供应商陶素生化(Topscience)与美国 TargetMol 形成战略合作关系,把这一系列实用的产品带到了中国,目前主推的1600种上市药物小分子化合物库已经为中国的客户提供了从50ul到5mg的多种选择,同时还为信号转导的客户提供了品质卓越的抑制剂小分子,方便客户进行信号通路的针对性研究。
Target Mol坐落于美国生物医药最发达的马赛诸塞州,这里有多达900家Healthcare领域的公司,从大型医院到Starup的生物技术公司,都对药物小分子的研究注以浓厚的兴趣。为了以最快的速度获得新型药物分子或进行细胞诱导的实验,各家公司都对于已经上市或报道的药物小分子进行研究。但通常这些药物小分子的收集工作是非常繁琐的,会耗费科学家们大量的时间。同时,由于分子和细胞水平的实验用量非常小,又增加了收集的难度和对实验材料的浪费。为了解决这个问题,Target-Mol公司推出了各种上市药物小分子库和活性抑制剂小分子库,以1mg,5mg的干粉和10mM的溶液向医药领域的客户提供灵活的产品集合,帮助生物学家和药学家得到了具有明确活性和毒性的上市药物研究的小分子,并收集了大量的抑制剂小分子以供科学家们进行细胞信号转导,细胞诱导,老药新用以及阳性对照的实验。
Target Mol company is located in Massachusetts'' where is the center of healthcare industry. There are as many as 900 biotech companies. No matter the leading university or startup biotech company'' these kind of companies and institutions pay much attention to the drug molecular compounds. In order to speed the process of new drug molecules discovery or cells induced experiments'' each company began to research approved drugs. However'' this kind work of drug collection not only waste money but is also time consuming. Target Molecule is built to help customer to find their target compounds at one stop at reasonable cost. The core product is the approved drug collection which includes 2''000 compounds. Base on the approved drug collection'' we have developed the natural product collection'' Drug Metabolism & Impurity Collection and Human endogenous compounds library. All the compounds can be offered by 1mg powder'' 5mg powder and the 10M concentration solution with DMSO. And inhibitor small molecular could be used for Cell signal transduction experiments'' cell inducting experiments'' new usage of old drugs and positive control experiments.
Target Mol collaborated with Topscience''Inc.(China) to launch new products in Chinese market. This product includes 1600 approved small molecular compound at diversified format''from 50ul to 5mg.Meanwhile''we provide high quality inhibitors to conveninent the research of signal pathways.
Target Mol官方网站:?http://www.targetmol.com ?